Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJtc Plc Regulatory News (JTC)

Share Price Information for Jtc Plc (JTC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 842.00
Bid: 844.00
Ask: 846.00
Change: 4.00 (0.48%)
Spread: 2.00 (0.237%)
Open: 845.00
High: 847.00
Low: 839.00
Prev. Close: 838.00
JTC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FCA moratorium - Delay to publication of results

24 Mar 2020 07:00

RNS Number : 3417H
JTC PLC
24 March 2020
 

24 March 2020

 

 

JTC PLC

(the "Company" and together with its subsidiaries "JTC" or the "Group")

 

Delay to the publication of FY19 results as requested by the FCA and Company response to COVID-19

 

 

JTC, the global provider of fund, corporate and private client services today announces that it will be complying with the Financial Conduct Authority's ("FCA") strong request to all listed companies to delay the publication of preliminary financial statements for at least two weeks from 22 March 2020.

 

The Company's full year results for the year ended 31 December 2019, which were due to be announced on Wednesday 1 April 2020, will now be released once the Company and the market receives further advice from the FCA.

 

The Board remains confident that the Group will report audited results for 2019 in line with current analyst consensus forecasts[1] and Company guidance provided, as detailed in the Trading Update announcement of 23 January 2020.

 

COVID-19 Response

 

JTC is a global business that is well diversified across clients, services and geographies. We are fortunate to have an extremely resilient business model with the following key features that are relevant to the current situation:

 

· Highly visible recurring revenue that is not linked to the assets we administer. Around 90% of revenue is recurring with an average client lifespan of 10 years and negligible mid-life attrition. To date, we have not seen any material impact on revenue from COVID-19.

 

· Strong cash conversion. JTC is a highly cash generative business with a stable, capital light cost base and margins of c.30% underlying EBITDA. We use our cash prudently to reinvest in the business, facilitate inorganic growth and support our dividend policy.

 

· A robust balance sheet relative to our facility of £150m, with no debt falling due until 2023. Headroom on leverage at year end was c. 50% of our banking covenant.

 

· Prudent debt levels. We are comfortable with our leverage level and have maintained it within our guidance range of 1.5x to 2.0x underlying EBITDA to net debt.

 

· Ability to deliver 'business as usual' service to clients under prolonged business continuity conditions. We are a people business enabled by technology. Our well-invested global platform, including our IT infrastructure, means that all employees globally are able to remote work seamlessly as required.

 

· Experienced management team. We have a track record spanning 32 years and have demonstrated our resilience and ability to grow through several periods of substantial external change.

 

· Shared Ownership model. At JTC, every employee is an owner of the business and we are privileged to have such a dedicated and talented workforce who have already demonstrated how committed they are to the interests of our clients and other stakeholders.

 

The Group's day-to-day response to COVID-19 is coordinated by the JTC Business Continuity Planning ("BCP") team, which is overseen by the Board and led by the Executive Management team. The BCP team has been taking action based on three core principles:

 

WELLBEING - actions that will support and protect the wellbeing of our people, clients and partners

 

SERVICE - actions that will ensure continued service excellence to our clients whilst minimising impact wherever possible

 

COMMERCIAL - actions that will support all JTC stakeholders and minimise any long-term commercial impact to the Group.

 

As well as extensive internal and client communications, the Company has been providing public updates on its response to COVID-19 since Thursday 5 March 2020 and these can be found at www.jtcgroup.com/news/jtc-and-covid-19/

 

Nigel Le Quesne, CEO of JTC, said:

 

"The wellbeing of our people, clients and partners remains our top priority and we are following government advice in all the countries where we operate. Our talented global teams have already shown flexibility and commitment through their ability to move seamlessly to remote working on a large scale, ensuring the ongoing delivery of excellent client service. We are fortunate to have an extremely resilient business model with highly visible recurring revenues and good cash conversion, as well as a strong balance sheet and a relatively low level of leverage. During this difficult time, our efforts will continue to focus on people, service and the long-term commercial success of the Group as we all face this global challenge together."

 

 

-ENDS-

 

 

Enquiries:

 

JTC PLC +44 (0) 1534 700 000

Nigel Le Quesne, Chief Executive Officer

Martin Fotheringham, Chief Financial Officer

David Vieira, Chief Communications Officer

 

Camarco +44 (0)20 3757 4985

Geoffrey Pelham-Lane

Kimberley Taylor

Monique Perks

 

 

 

About JTC

 

JTC is an award-winning provider of fund, corporate and private client services. Founded in 1987, the company employs c.750 people across its global office network and is trusted to administer assets of c.US$110 billion.

 

JTC is committed to its shared ownership culture and philosophy, with management and staff holding over 20% of the equity in the firm, clearly aligning the interests of clients, employees and other stakeholders.

 

www.jtcgroup.com

 

 

Important Notices

The person arranging release of this announcement on behalf of JTC is David Vieira (Chief Communications Officer).

The release, publication or distribution of this announcement in jurisdictions other than the United Kingdom may be restricted by law and therefore any persons who are subject to the laws of any other jurisdiction should inform themselves about, and observe, any applicable requirements. This announcement has been prepared for the purposes of complying with the Listing Rules and MAR and the information disclosed may not be the same as that which would have been prepared in accordance with the laws and regulation of any jurisdiction outside of England.

This announcement contains forward looking statements. No forward-looking statement is a guarantee of future performance and actual results or performance or other financial condition could differ materially from those contained in the forward-looking statements. These forward-looking statements can be identified by the fact they do not relate only to historical or current facts. They may contain words such as "may", "will", "seek", "continue", "aim", "anticipate", "target", "projected", "expect", "estimate", "intend", "plan", "goal", "believe", "achieve" or other words with similar meaning. By their nature forward looking statements involve risk and uncertainty because they relate to future events and circumstances. A number of these influences and factors are outside of the Company's control. As a result, actual results may differ materially from the plans, goals and expectations contained in this announcement. Any forward-looking statements made in this announcement speak only as of the date they are made. Except as required by the FCA or any applicable law or regulation, the Company expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained in this announcement.

 

 

 

[1] https://www.jtcgroup.com/investor-relations/analyst-consensus/

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCQZLBLBXLZBBQ
Date   Source Headline
24th Apr 20247:00 amRNSPDMR Shareholding
22nd Apr 20243:51 pmRNSHolding(s) in Company
22nd Apr 20247:00 amRNSAcquisition of First Republic Trust Co of Delaware
18th Apr 20247:00 amRNSAnnual Financial Report and Notice of AGM
10th Apr 20247:00 amRNSVesting and Grant of Share Plan Awards
9th Apr 20247:00 amRNSFull year results for year ended 31 December 2023
20th Mar 20245:59 pmRNSHolding(s) in Company
4th Mar 20247:00 amRNSCompletion of Acquisition and Issue of Equity
29th Feb 202410:33 amRNSHolding(s) in Company
1st Feb 20247:00 amRNSPre-close Full Year Trading Update
31st Jan 20247:00 amRNSTotal Voting Rights
12th Jan 20247:00 amRNSPayment of SALI earnout and issue of equity
12th Dec 20234:39 pmRNSTR1: Notification of Major Holdings
7th Dec 20237:00 amRNSHolding(s) in Company
24th Nov 20237:00 amRNSAcquisition of Blackheath Capital Management LLP
22nd Nov 202310:22 amRNSHolding(s) in Company
3rd Nov 20237:05 amRNSHolding(s) in Company
2nd Nov 20237:00 amRNSHolding(s) in Company
25th Sep 20237:00 amRNSDirector's Share Dealing
19th Sep 20237:00 amRNSPDMR's Share Dealing
12th Sep 20237:00 amRNSInterim results for the period ended 30 June 2023
1st Sep 20239:00 amRNSTotal Voting Rights
10th Aug 202310:42 amRNSHolding(s) in Company
9th Aug 20231:57 pmRNSHolding(s) in Company
3rd Aug 20237:00 amRNSCompletion of SDTC Acquisition and Issue of Equity
25th Jul 20237:00 amRNSInterim Trading Update and Notice of Results
21st Jun 20237:00 amRNSIssue of Equity and Voting Rights
20th Jun 20239:43 amRNSHolding(s) in Company
15th Jun 20237:00 amRNSResults of Placing
14th Jun 20234:36 pmRNSProposed Placing of New Ordinary Shares
14th Jun 20234:35 pmRNSAcquisition of South Dakota Trust Company
9th Jun 20239:43 amRNSHolding(s) in Company
31st May 20237:00 amRNSTotal Voting Rights
24th May 20238:12 amRNSResult of AGM
4th May 20237:00 amRNSIssue of Equity and Voting Rights
21st Apr 20237:00 amRNSAnnual Financial Report and Notice of AGM
12th Apr 20237:00 amRNSVesting and Grant of Performance Share Plan Awards
11th Apr 20237:00 amRNSFull year results for year ended 31 December 2022
7th Mar 20231:57 pmRNSHolding(s) in Company
13th Feb 202312:08 pmRNSHolding(s) in Company
2nd Feb 20237:00 amRNSPre-close Full Year Trading Update
14th Dec 20227:00 amRNSDirector/PDMR Shareholding
9th Dec 20222:52 pmRNSFormation of Governance and Risk Committee
1st Nov 20227:00 amRNSCompletion of NYPTC Acquisition
13th Sep 20227:00 amRNSInterim results for the period ended 30 June 2022
26th Aug 20227:00 amRNSProposed Acquisition of NYPTC
27th Jul 20227:00 amRNSEIP Award Vesting
22nd Jul 20227:00 amRNSPre-close Interim Update and Notice of Results
15th Jul 20227:00 amRNSNomination Committee Appointment
8th Jul 202211:43 amRNSDirector's Share Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.